إعـــــــلان

تقليص
لا يوجد إعلان حتى الآن.

ماذا تعرفون عن هذا التحليــــــل

تقليص
X
 
  • تصفية - فلترة
  • الوقت
  • عرض
إلغاء تحديد الكل
مشاركات جديدة

  • ماذا تعرفون عن هذا التحليــــــل

    الســـــــــلام عليكم ورحمة الله تعالى وبركاته

    اخوتي واخواتي الكرام

    أحتاج مسااعدتكم كونكم متخصصين

    أريد كل التفاصيل الممكنة عن هذا التحليل

    albumine to creatinine Ratio

    أو بالعربي مقارنة الألبومين بالكرياتينين

    ولكم خالص الشكر و واافر التقديـــــــــــــر

    وجزاكم الله خير:sm180:

    أستغفر الله اللذي لا إله الا هو الحي القيوم وأتوب اليه
    *
    :sm182:
    لا إله الا أنت سبحانك إني كنت من الظالمين

  • #2
    albumine : عبارة عن بروتين

    creatinine : عبارة عن non_protein nitrogenous compound

    في هذه الحالة نريد ان نعرف كمية البروتين بالنسبة ل non_protein عان نعرف هل نشاط الكبد والكلى سليمة او شيئ اخر


    تحياتي الك

    تعليق


    • #3
      Microalbumin = (Microalbumin/Creatinine Ratio)

      • The urinary microalbumin (MA) test is an immunoassay that is at least 30-fold more sensitive than standard urine protein assays. It is the earliest available indicator for the development of diabetic complications. These may include diabetic nephropathy, cardiovascular disease and hypertension
      • The urine protein test will detect any protein, even bacterial proteins, and some other chemical substances. The MA test only detects human serum albumin, the primary protein present in pathological proteinuria. This markedly improved specificity can help insurance companies eliminate adverse underwriting actions based on contaminated urine specimens from otherwise healthy applicants.
      • Persistently elevated MA, not elevated total urine protein, defines diabetic nephropathy.
      • Diabetic complications may be determined by elevated MA 5 to 10 years earlier than total urine protein. For this reason, the American Diabetes Association recommends regular MA testing in Type 1 and Type 2 diabetics.
      • Type 2 diabetics with elevated MA have a 4- to 5-fold increased risk of both CVD occurrence and CVD mortality when compared to Type 2 diabetics with normal MA measurements. Increased CVD mortality is the primary mortality risk for both Type 1 and Type 2 diabetes.
      • Insurance urine specimens are not sterile. They may be contaminated with seminal fluid, mucous or other bodily fluids, which may cause an elevated total urine protein result. If the urine preservative tablet is not left in the specimen, bacteria can grow in urine and produce bacterial proteins, which will also result in an elevated total urine protein. None of these contaminates will cause an elevated MA test result.
      • MA testing can eliminate the need to collect additional urine specimens or delay issuing policies on applicants whose elevated total urine protein was only due to such contaminates. This can reduce testing costs, eliminate unnecessary delays, and improve policy issue rates. About 20 to 30% of all applicants with elevated urine protein results will have normal MA results and can be underwritten without the need for adverse action.
      • Order MA testing on applicants who are known to be diabetic or who have one or more of the following indicators for glucose intolerance: an elevated serum glucose, an elevated serum fructosamine, an elevated blood hemoglobin A1c (glycated hemoglobin), or detectable urine glucose.
      • Microalbuminuria is not specific for diabetes. It may also be associated with hypertension (high blood pressure), some lipid abnormalities, and several immune disorders. Elevated results may also be caused by vigorous exercise, blood in the urine, urinary tract infection, dehydration, and some drugs.
      :extra77:

      تعليق


      • #4
        أتقدم بالشكر الجـــــــزيل مع وافر التقدير لكما

        Dr.sanary

        شكرا على الإفادة

        dr.moz

        شكرا على الشرح المطول وجزاك الله خير

        أستغفر الله اللذي لا إله الا هو الحي القيوم وأتوب اليه
        *
        :sm182:
        لا إله الا أنت سبحانك إني كنت من الظالمين

        تعليق

        يعمل...
        X